The devil in the details: thorough assessment of evidence and ethics is needed in evaluating new HIV prevention methods.
National Institutes of Health, Bethesda, MD 20817, USA. dawsonl@niaid.nih.gov
Liza
L
Dawson
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D032984:Ethics, Research; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006297:Health Services Accessibility / Q000941:ethics*; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D011322:Primary Prevention / Q000941:ethics*; D057212:Therapeutic Equipoise
D019380:Anti-HIV Agents